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Abstract
Amorphous aggregation is a major problem for protein biopharmaceuticals, and aggregate
formation in a drug formulation can have serious health implications for the patient. In many
cases, an immunogenic response is generated from the administration of a drug product containing
aggregated protein. This becomes especially significant when the patient requires long-term or
repeated administration of the drug, because the likelihood of a severe immune response increases.
While the prevention of protein aggregation is critically important for the future of protein
pharmaceuticals, the process is still poorly understood. The lack of understanding regarding non-
fibrillar aggregation is largely due to the fact that assembly is difficult to study. In particular the
role that various structural features (i.e. α-helix, β-structure, disulfide bonds) play in the
aggregation process varies with the amino acid sequence and is dependent upon tertiary structure
and solution conditions. Well-structured proteins do not readily aggregate in solution, whereas
partially unfolded proteins tend to aggregate rapidly and often become insoluble. Here, we present
a unique and simple system for studying amorphous protein aggregation. We have previously
reported the isolation of the basic leucine zipper (bZIP) domain of activating transcription factor 5
(ATF5), a protein notable for its potential as a pharmaceutical target for treatment of glioblastoma
multiforme. This domain consists of a single α-helix and possesses a single cysteine residue. It is
only partially structured and displays marginal stability in solution under physiological conditions.
We have modulated solution conditions that affect backbone solubility and the oxidation state of
the thiol to successfully investigate the role that α-helical structure and disulfide bond formation
play in protein stability. Our data indicate that covalent cross-linking helps to retain ATF5’s
helicity, which inhibits the formation of large aggregates. These studies have led to the
identification of stabilizing conditions for ATF5, which will enable further study of the protein as
a pharmaceutical target. Moreover, this work has general implications for analyzing stability of
helical proteins in vitro and the specific atomic-level interactions in ATF5 that contribute to
instability and self-association.
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Amorphous aggregation is a common phenomenon and a major obstacle to handling
proteins in vitro. The aggregation of proteins isolated for use as pharmaceutical products
poses a serious concern, as aggregates can stimulate the immune system, which may have
devastating affects on the patient.1–3 Although the study of protein aggregation has wide-
reaching implications, the process by which aggregation occurs is still difficult to predict.
The study of amyloids has provided understanding about the structure and formation of
fibrillar aggregates, but a lack of data regarding amorphous structure has prevented
verifiable application to amorphous aggregation. In particular, the role that disulfide bonds
play in this process is poorly understood, because it varies among different systems. Reports
indicate in some instances that disulfide bond formation promotes protein aggregation, yet in
others it dampens this process.4–8 These effects appear to be largely protein specific and
dependent on features of tertiary structure. Alpha-helices can also play an important role in
aggregation. In most instances, retention of α-helical structure has been linked to improved
protein stability; 9, 10 however, several recent reports indicate that α-helical structure can
facilitate aggregate formation.11–13
The lack of understanding surrounding non-fibrillar aggregation is largely due to the fact
that the assembled species lacks a regular repeating pattern, making it is difficult to study.
Well-structured and natively disordered proteins do not readily aggregate in solution,
whereas partially unfolded proteins tend to aggregate rapidly, suggesting structured features
facilitate aggregation. Here we present a unique and simple system, which is amenable to
investigating the mechanism of protein aggregation involving a helix to coil transition. We
have previously reported the isolation of the bZIP domain of activating transcription factor 5
(ATF5), a protein notable for its potential as a pharmaceutical target for treatment of
glioblastoma multiforme.14 This domain consists of a single α-helix and possesses a single
cysteine residue. It is only partially structured (~25% helix) and displays marginal stability
in solution under physiological conditions. We have tested solution conditions that modulate
helical propensity and the oxidation state of the thiol, to successfully investigate the role that
α-helical structure and disulfide bond formation play in protein stability. These studies have
led to the identification of stabilizing conditions for ATF5, which will enable further study
of the protein as a pharmaceutical target and provided a model system for further
examination of residue-specific contributions to the formation of amorphous aggregates.
Materials and Methods
Protein Expression and Purification
The cDNA of ATF5 was obtained through ATCC (MGC-842) and the bZIP domain was
PCR amplified and inserted into a Novagen (San Diego, CA) pET-42b vector as described
previously.14 Site-directed mutagenesis was performed to create the C240A point mutation
in the bZIP region using the following primers:
5’GAGGCCCTGGAGGGCGAGGCCCAGGGGCTGGAGGCACGG (forward primer), 5’-
CCGTGCCTCCAGCCCCTGGGCCTCGCCCTCCAGGGCCTC (reverse primer). Plasmids
were transformed into Novagen BL21(DE3) E. Coli for expression. Purification was done
using a refolding procedure described previously.14 Protein concentrations were determined
using a standard Bradford assay. ATF5 purification and isolation was confirmed using SDS-
PAGE and LC/MS.14 These methods were also used to confirm intermolecular disulfide
bond formation for wild-type ATF5.14 Isotopic labeling for two-dimensional NMR was
accomplished with the substitution of 15N-ammonium chloride. The 15N-ammonium
chloride (>99% N-15) was obtained from Spectra Stable Isotopes (Columbia, MD).
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Circular dichroism (CD) spectra were acquired with a Jasco-810 polarimeter (Tokyo, Japan)
equipped with a Peltier-type temperature controller and a six-position sample holder.
Samples were prepared at a final protein concentration of 100 µM in 20 mM MES buffer at
pH 6.0 in the absence or presence of dithiothreitol (DTT) or trifluoroethanol (TFE). Scans
were performed at 4°C from 260 to 190 nm in a 0.1-cm path length cell. A scanning speed
of 50 nm/min and a response time of 8 sec were used. The selected bandwidth was 5 nm and
the data pitch was 1 nm. Scans were run in duplicate for each sample and two samples were
prepared and analyzed for each set of solution conditions. Using the Jasco Spectra Manager
v1.18.00 software the measured values were converted to molar ellipticity. The resulting
average and standard deviations were plotted for each condition using Plot. Percent helicity
was calculated using the mean residue ellipticity observed at 222 nm as previously
described.14, 15
To evaluate protein stability the absorbance at 222 nm was monitored at a function of
temperature. The temperature was adjusted from 4 to 85°C at a ramping rate of 15°C/hour
and the absorbance was monitored every 0.5°C. The results were converted to molar
ellipticity using the instrument software. Two samples were prepared and analyzed for each
set of solution conditions. The resulting average and standard deviations were plotted using
Plot. Midpoints of thermal transition were calculated using Microcal Origin sigmoidal fit
graphing tools. None of the solution conditions used produced signals above background at
any temperature and therefore, no buffer subtraction manipulations were performed.
Static Light Scattering
Static light scattering (SLS) data were acquired with a Photon Technology International
(PTI) spectrafluorometer (Lawrenceville, NJ) equipped with a Peltier-type temperature
controller and a four-position sample holder. Samples were prepared at a final protein
concentration of 100 µM in 20 mM MES buffer at pH 6.0 in the absence or presence of
dithiothreitol (DTT) or trifluoroethanol (TFE). The intensity of scattered light was measured
as a function of temperature and detected at an angle of 90° to the light source by a
photomultiplier tube. An arc lamp white light source was used in all cases. The excitation
wavelength was set at 275 nm. The emission wavelength range was set from 250 nm to 350
nm. Spectra were obtained following a 5 min equilibration period at each temperature. Data
were collected every 2.5°C between the temperature range of 4 to 81.5°C. The background
was subtracted from each data point based on a blank containing the corresponding buffer
solution. Two samples were prepared and analyzed for each set of solution conditions. The
resulting average and standard deviations were plotted using Plot.
Dynamic light scattering
The average hydrodynamic diameter was monitored as a function of temperature using a
Brookhaven (Holtsville, NY) BLS-9000 DLS instrument equipped with a 50 mW HeNe
diode laser operating at 532 nm and a Brookhaven BI-200SM goniometer. Samples were
prepared in 20 mM MES buffer pH 6.0 at a final concentration of 100 µM. Five consecutive
30 sec data collection intervals were taken every 2.5°C over the range of 10 to 90 °C. Light
scattering was monitored 90° to the incident light and autocorrelation functions were
generated using a Brookhaven BI-9000AT digital autocorrelator. The hydrodynamic
diameter was calculated from the translational diffusion coefficient using the Stokes-
Einstein equation.16
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Two-dimensional 1H-15N heteronuclear single quantum coherence (HSQC) spectra were
recorded at 25°C using a Bruker AVANCE 800 MHz spectrometer equipped with a triple-
resonance CRYO-probe with pulse field gradients. Samples were prepared at a
concentration of 0.2 mM in 50 mM sodium phosphate, 100mM NaCl pH 6.5, containing 5%
D2O. Water suppression was accomplished using flip-back pulses. Data were acquired in
128 scans with 2048 points in 1H and 128* increments in 15N. 1H chemical shifts were
referenced with respect to an external DSS standard in D2O.17 Indirect referencing relative
to 1H was determined for 15N, assuming a ratio of 15N/1H = 0.101329118. Data were
processed using NMRPipe and Sparky software.18, 19
Results
CD spectroscopy was used to investigate the influence of a single intermolecular disulfide
bond (C240–C240) on the structure of the bZIP domain of ATF5. The spectra reveal
absorption characteristics consistent with the presence of α-helical structure for both the
disulfide-bound dimer and the C240A monomer (Figure 1A). This is depicted by the double
absorption minima pattern detected at 222 nm and 208 nm.20 The ratio of 222 to 208 nm is
0.84 for wild type and 0.85 for C240A, which is consistent with α-helical but not coiled-coil
structure.21, 22 An increase in helical content is observed for the dimer in comparison to the
monomer. This difference can be quantified for each species using the mean residue ellipticy
at 222 nm.14, 15 The percent helicity calculated for the dimer under these conditions is
23.4% ± 0.3%, whereas the percent helicity of the C240A monomer is 19.0% ± 1.0%.
Upon the addition of reducing agent to wild-type (WT) ATF5 (10 mM DTT), a decrease in
absorption signal that corresponds to α-helix is observed (Figure 1B). The absorption
intensity for the reduced WT more closely resembles that of the C240A monomer under
reducing conditions with a calculated percent helicity of 17.9% (± 0.2%) and 16.7% (±
0.1%), respectively. This indicates the intermolecular disulfide bond is responsible for the
increased helicity originally observed for the dimeric species. It is important to note that the
decrease in absorption intensity observed at 208 nm relative to 222 nm in the presence of
DTT is due to substantially increased interference caused by DTT on the detection at shorter
wavelengths. For this reason, absorption measurements taken at wavelengths below 210 nm
in the presence of DTT should be considered less accurate. As such, the ratio of 222 nm to
208 nm was not assessed because the interpretation of this value is also unreliable for
determining α-helical vs coiled-coil content.
The impact of the intermolecular disulfide bond on thermal stability was evaluated by
monitoring the α-helix CD absorption signal at 222 nm as a function of temperature. A
decrease in absorption signal at 222 nm indicates a loss of secondary structure, which
reflects protein unfolding. The disulfide-bound dimer is more stable than the C240A
monomer. The calculated melting temperature (Tm) of the dimer is 55.5°C, whereas it is
15.9°C for the monomer (Figure 2A). In the presence of reducing agent (10 mM DTT) the
Tm for the C240A mutant remains relatively unchanged (15.1°C), whereas the melting curve
for the dimer shifts dramatically to more closely resemble that of the monomer (Figure 2B).
The calculated transition temperature for the dimer under these conditions is 19.9°C.
Notably, unfolding of all forms of ATF5 was found to be largely irreversible due to
precipitation of aggregated species (data not shown).
The effect this intermolecular disulfide bond has on protein aggregation was then evaluated
using a static light scattering assay. The intensity of scattered light was measured as a
function of temperature for the two forms of ATF5. In this assay, an increase in the intensity
of scattered light indicates increased aggregate formation. The data show that the onset of
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aggregation is more rapid, and the extent of aggregation is greater for the C240A mutant
compared to the WT under non-reducing conditions (Figure 3A). The onset of aggregation is
more gradual and the extent lessened for the disulfide-bound dimer (Figure 3A). Upon
reduction of the disulfide bond via the addition of reducing agent (10 mM DTT), the
scattering profile of the dimer more closely parallels that of the C240A monomer (Figure
3B). The decrease in signal seen at higher temperatures in Figure 3B indicates the formation
of very large aggregates that have settled out of solution, resulting in diminished absorbance
intensity. This was verified using dynamic light scattering analysis, which indicated that the
average hydrodynamic diameter of protein in solution was much greater in the presence of
DTT (See Supporting Information; Table S1). Clearly, reduction of the disulfide bond
decreases thermal stability, as the two proteins now behave similarly, but it is also apparent
that the inclusion of DTT in solution has an additional adverse effect on protein stability,
possibly due to the more hydrophobic character or decreased dielectric constant of this co-
solvent.
The effect that α-helical structure has on protein stability was evaluated using the addition
of the co-solvent trifluoroethanol (TFE) to induce helical structure. The use of TFE for the
purpose of inducing protein structure is common and well cited.23, 24 TFE is added to
peptides to enhance α-helicity, because the solubility of the backbone changes. Low
percentages of TFE typically increase helicity, but at high concentrations (often >40%) β-
sheets may form in some peptides.23 The impact of TFE on the structure of ATF5 was
assessed using CD spectroscopy. The helical content of both the disulfide-bound dimer and
the C240A monomer increased in a dose-dependent fashion upon the addition of TFE within
the experimental range used (Figure 4). The increase in helicity observed for a given amount
of TFE added was greater for the C240A mutant than for the dimer, but at 10% TFE and
above both forms displayed equivalent amounts of helical structure. The percent helicity was
quantified as described above for both forms of ATF5. The dimer displayed a percent
helicity of 25.5% (± 0.6%), 30.8% (± 0.6%), and 39.3% (± 1.0%) in the presence of no TFE,
10% TFE and 20% TFE, respectively. The comparative values for the C240A monomer
under the same conditions are 19.5% (± 0.3%), 30.5% (± 0.3%), and 42.0% (± 2.2%),
respectively.
The thermal stability of both forms of ATF5 in the presence of increasing concentration of
TFE was investigated by monitoring the α-helical CD absorption signal at 222 nm as a
function of temperature. The melting profiles of both forms changed in the presence of TFE
(Figure 5). The data show that increasing the helicity of either form of ATF5 improves
thermal stability, because greater α-helical structure is retained at all temperatures in the
presence of TFE. A standard quantitative analysis comparing Tm values is not possible for
these data, because the melting profiles in the presence of 10% and 20% TFE could not be
fit to a sigmoidal curve. The melting temperature calculated for the WT form of ATF5 in the
absence of TFE is 56.0°C. At that same temperature in the presence of 10% and 20% TFE,
there is greater helical structure present. The molar ellipticity values for the WT dimer at
56°C in the presence of 0%, 10% and 20% TFE are −426,189, −581,870, and −630946,
respectively. This equates to approximately 9% more α-helix at 10% TFE than at 0% TFE,
and 3% more helix at 20% TFE than at 10%. The melting temperature calculated for the
C240A monomer in the absence of TFE is 17.2°C.
The molar ellipticity values for the C240A mutant at 17°C in the presence of 0%, 10% and
20% TFE are −428,822, −653,246 and −846,000, respectively, equating to 12% more helix
at 10% TFE than 0% TFE, and 11% more helix at 20% TFE than 10% TFE.
Analysis of static light scattering data was used to evaluate the effect of helicity on protein
aggregation. Increasing the α-helical structure of both the cross-linked WT dimer and the
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C240A monomer prevents aggregation (Figure 6). The maximum intensity of scattered light
detected for the WT form is 259,404, 150,731 and 139,743 in the presence of 0%, 10% and
20% TFE, respectively. Notably, a greater difference in the extent of aggregation is
observed between 0% and 10% TFE than between 10% and 20% TFE. This same trend is
observed for the C240A monomer, where the maximum intensity of scattered light detected
in the presence of 0%, 10% and 20% is 779,386, 277,567, and 248,188, respectively. The
greatest impact on aggregation in all cases is observed for the C240A mutant in the presence
of 10% TFE, where the inclusion of the co-solvent dramatically reduces the onset and extent
of aggregation. The impact on aggregation for the WT form at the same concentration of
10% TFE is much less dramatic, even though the percent helicity induced is roughly the
same as that of the C240A monomer (approximately 30%). At low temperatures, the
addition of TFE leads to a small amount of increased light scattering for both the WT and
C240A. There is more scattering at 20% TFE compared to 10% TFE, suggesting that an
alternative mode of association may be responsible for aggregation in the TFE-containing
samples.
NMR experiments were performed to evaluate general differences in structure between the
WT and C240A forms of ATF5 at higher resolution. The 2D 1H-15N HSQC experiment
used here selectively detects all NH pairs in the protein and correlates each 1H to the directly
attached 15N atom. The resultant spectrum is considered a “fingerprint” of the protein,
because the chemical shifts depicted reflect the conformationally-weighted average of the
environment experienced by the nuclei, which is defined by the overall protein fold.
Consequently, the 1H-15N HSQC experiment can provide a quick indication of protein
structure. A well-behaved globular protein will display good signal dispersion, typically
ranging from 6 to 12 ppm on the 1H-axis and 100–140 ppm on the 15N-axis. This dispersion
results from the presence of stable, structural features that confine the individual nuclei to
unique chemical environments. More disordered proteins typically have peaks clustered
more closely around random coil values (~8.3 ppm in 1H). This is because, on average, the
nuclei experience more similar chemical environments in solution than in the structured
protein. The HSQC spectra of proteins composed of only a single helix, like the bZIP of
ATF5, are difficult to interpret without full assignments and additional data, because in a
standard alpha helix, all the amides are in similar environments, which can result in
overlapping NMR signals. Typically, when bZIP proteins functionally dimerize they interact
to form a two-stranded coiled-coil. Higher-order protein structure, such as coiled-coil, would
place the NH nuclei in more distinct chemical environments, resulting in greater dispersion
of the NMR signal, as has been demonstrated experimentally for a number of bZIP proteins
examined structurally using solution NMR.25–29
An overlay of the 2D HSQC spectrum of the C240A mutant onto the WT spectrum shows
that the chemical shifts for both forms are largely clustered around 8.3 ppm in 1H and only a
few differences in resonance positions between the spectra are apparent (Figure 7). This
indicates the average structure of the two forms is quite similar and both proteins are
conformationally labile. The limited chemical shift dispersion observed for both forms of
ATF5 represents α-helix and/or random coil structure. The lack of dispersion in the NMR
spectra further indicates coiled-coil structure is not developed, even in the obligate wild-type
dimer. This is consistent with the CD spectra in which the ratio of 222 to 208 nm indicate α-
helix is present but coiled-coil structure is not. The unique red peaks in the WT dimer likely
correspond to residues adjacent to C240 involved in the helical region that are stabilized by
disulfide bond formation. The NH signal generated by the side chains of Asn and Gln
residues cluster in a different chemical shift range and account for the signal observed
between 6.8 and 7.6 ppm on the 1H -axis. There is little evidence for the existence of a
coiled-coil structure for either form of ATF5, even at the high concentrations required for
these studies. These data suggest that despite the presence of 23% helical content in the
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covalent dimer and its resistance to aggregation when the helix is maintained, ATF5 does
not develop well-defined tertiary structure. Interestingly, the addition of 20% TFE alters the
spectrum to only a small extent (data not shown), suggesting TFE may temporarily stabilize
residues already prone to helix formation rather than propagating helicity to other portions
of the sequence.
Discussion
ATF5 belongs to the basic leucine zipper (bZIP) family of transcription factors. These
proteins function as dimers that bind DNA and regulate transcription. The bZIP domain,
present in all family members, contains a repeating pattern of leucine in every seventh
position, which facilitates dimerization through formation of a parallel two-stranded coiled-
coil.30 Favorable hydrophobic interactions between residues in the a and d positions of the
leucine zipper heptad in conjunction with attractive electrostatic interactions between
residues in the e and g positions typically drive coiled-coil formation in bZIP proteins.30 The
basic regions of each monomer then bind DNA in what has been described as a “scissors-
grip” model of binding.31 bZIP proteins can either homodimerize or heterodimerize with
other bZIP family members. Previous findings suggest that ATF5 forms a bZIP homodimer
(Figure 8).32 We have identified some favorable interactions that exist in our helical wheel
diagram of the ATF5 homodimer that could assist in formation of a coiled-coil. For instance,
the leucine residues in the d position (boxed in black) have a high propensity to adopt a
helical conformation and are known to pack favorably in two-stranded coiled-coils.33–35 We
have shown that disulfide bond formation at the cysteine residue in the a position (boxed in
black) retains helical structure, which could be a stabilizing force for a coiled-coil.
Additionally, there are a few favorable electrostatic interactions that exist between residues
in the e and g positions (depicted by black double-headed arrows and boxed) that could help
stabilize a coiled-coil homodimer. However, there are also several unfavorable interactions
present here that are not found in other bZIP coiled-coils. The valine residues in the d
position (outlined in red) have a much lower propensity to adopt helical structure.33 β-
branched amino acids, like valine, are also not favored in the packing arrangement of two-
stranded coiled-coils.34, 35 A series of unfavorable electrostatic interactions exist between
residues in the e and g positions (delineated by red double-headed arrows and boxed) that
would further prevent formation of a stable coiled-coil. We have collected structural data on
the bZIP domain of ATF5 at high concentrations using CD and solution NMR,14 and our
data indicate that the ATF5 protein does not form a stable coiled-coil in solution under
physiological pH, ionic strength and reducing conditions.14 The absence of valine residues
and repulsive electrostatic interactions in the ATF4 and other bZIP coiled-coil structures
implies that these features are responsible for the prevention of a stable coiled-coil for the
ATF5 homodimer.
ATF5 shares 74% sequence homology with another bZIP protein family member, ATF4
(Figure 9). A crystal structure has been solved for ATF4, in which the protein participates in
formation of a bZIP heterodimer with CCAAT enhancer binding protein β (C/EBPβ).36 In
this structure, ATF4 is shown to exist as a very straight α-helix, while C/EBPβ curves to
wrap around ATF4 and create the coiled-coil. This is a unique feature of ATF4, as most
bZIP proteins display more flexibility, with two bZIP monomers curving equally to wrap
around each other.37–41 The structure suggests that the rigidity of the ATF4 α-helix
disfavors homodimerization, i.e. coiled-coil formation, and therefore must dimerize with a
more flexible partner. The lack of stable homodimer formation under reducing conditions
suggests ATF5 may heterodimerize in vivo and that it is prone to aggregation in vitro
because its hydrophobic side chains are exposed and unable to form native interactions
without the alignment imposed by covalent attachment.
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Alternatively, it has been suggested that intermolecular disulfide bond formation might
facilitate formation of an ATF4 or ATF5 homodimer.36 A unique cysteine residue is located
at the center of the bZIP region of ATF4.36 This analogous cysteine is positioned such that it
would be at the interface of a coiled-coil dimer. ATF4 and ATF5 are the only bZIP proteins
that contain a cysteine residue in this position, suggesting a functional role for this residue in
vivo. We have collected NMR data in the presence and absence of this intermolecular
disulfide bond for ATF5. The notable lack of dispersion in 1H signal in the spectra of both
the reduced monomer and oxidized dimer compared to spectra of other coiled-coil proteins
indicates disulfide bond formation at this position does not confer formation of a stable
coiled-coil (Figures 7 and 8). This disulfide bond does, however, play a role in retention of
α-helical structure and physical stability of the protein to resist aggregation. If
homodimerization has a biological function, the protein is likely to be redox regulated, as
has been reported for other transcription factors.42
A naturally occurring mutant of apolipoprotein A-I (ApoA-I) known as the Milano variant
(ApoA-IM) was found to affect the stability of this protein in a parallel manner to that
observed for ATF5. The Milano mutation introduces a non-native Cys residue that results in
the formation of a disulfide-bonded homodimer. Cys substitution significantly increases
both the percent helical content and the stability of this protein at high concentration.43
Cross-linking stabilizes a conformational change in ApoA-IM that increases the helical
content to match that of the native dimerized form, which is present at higher concentrations
of protein. At lower protein concentration this mutation and other substitutions at the same
site leads to diminished helicity and stability due to disruption of a salt bridge.44 Addition of
TFE to monomeric ApoA-I also increases its helical content to match that of the Milano
form and concomitantly improves stability of the native protein against aggregation. ApoA-I
is prone to form amyloid aggregates in vivo, whereas the disulfide-bound Milano form
resists aggregation.45 Interestingly, mutation at the same or adjacent positions in the protein
that do not confer covalent attachment render ApoA-I more susceptible to aggregation.45
Despite that ApoA-I and ATF5 are unrelated in sequence or function, these two systems
display parallel behaviors with respect to the influence of helicity and disulfide cross-linked
dimerization on stability and aggregation. Further investigation of ATF5 and comparison to
ApoA-I may provide insights to better understand the basis of how helical structure and
dynamics influence stability and aggregate formation.
The bZIP domain of ATF5 contains several valine residues instead of leucine residues at the
C-terminal end of this region. While valine residues are commonly located in the a-position
of the leucine zipper heptad, they rarely occupy the d-position. ATF5 is the only bZIP
protein to possess three consecutive valines in this domain. ATF4 encodes only a single
valine residue in the last d-position of its bZIP domain. It is not known what affect these β-
branched amino acids would have on the binding partner selectively of ATF5 in vivo, but
they seem to prevent coiled-coil formation and are likely to be a key component of the
protein’s instability in vitro.
Our data show that the bZIP domain of ATF5 is only partially structured in solution, with its
percent helicity increasing from 19.0% to 23.4% in the presence of the intermolecular
disulfide bond. Using the DISEMBLTM server we predicted the intrinsic disorder of this
domain (data not shown).46, 47 The N-terminal basic domain (residues 203–238) and the end
of the C-terminal leucine zipper domain (residues 275–282) are the most likely regions to be
disordered. Additionally, a number of studies have shown that the helical propensity of
leucine is much greater than valine.33 This suggests that the central portion of the leucine
zipper of ATF5 is most likely to be helical. There are seventeen residues between the
cysteine at position 240 and the valine at position 257, which make up the first half of the
leucine zipper domain. If this region displayed 100% helicity and the rest of the protein was
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disordered, the predicted percent helicity would be 22.8%. This matches closely with the
experimental values obtained for ATF5. An intermolecular disulfide bond positioned at
cysteine 240 would likely help to stabilize the helical structure in this region by constraining
the two chains and increasing intermolecular contact between them.
Computational methods for predicting protein aggregation have been developed, and we
used several to examine ATF5. TANGO is a statistical mechanical model used to identify
nucleation sites for aggregation based on the observations that aggregates often contain
increased β-structure and the core regions of an aggregate are completely buried, such that
nucleating sequences will have their hydrogen bonding potential largely satisfied.48 This
program predicts that the region most likely to initiate aggregation in ATF5 lies between
residues 260 and 276. This corresponds to the valine-containing portion of the leucine
zipper, which is largely hydrophobic (Figure 9). AGGRESCAN is another sequence-based
tool, which relies upon the aggregation-propensity for each of the individual amino acids to
identify sequences likely to aggregate.49 An evaluation of the bZIP domain of ATF5
identified the region contained between residues 265 and 273 as most likely to aggregate,
which again, falls within the valine-containing portion of the leucine zipper. Based upon this
information, it is likely that the structural features demonstrated to impart improved stability
to ATF5 function protect the less-structured and aggregation-prone valine-containing
portion of the protein from intermolecular association. A third program was used to evaluate
the propensity of protein molecules to self-associate. Prediction of amyloid structure
aggregation (PASTA) is based on the alignment observed in most cross-β structures.50
PASTA predicted that it is unlikely for ATF5 to form cross-β fibrillar aggregates, which is
consistent with our experimental observations of amorphous aggregates. The PASTA
results, however, indicated that the antiparallel alignment of ATF5 in solution is
energetically preferred over parallel alignment. This small preference could explain why
aggregates form more rapidly between monomers. Covalent dimerization may not so much
alter the structure of the monomer as constrain the Val-containing sequences in close
proximity and provide an adjacent hydrophobic surface with which to interact.51
We have shown that the retention of α-helical structure, either through formation of an
intermolecular disulfide bond or via the addition of TFE, prevents rapid, thermally-induced
protein aggregation. Based on the prediction results derived from first principles, it is most
likely that the disordered regions of ATF5 play a role in initiating the process of aggregation
rather than the uncoiled helical sequence. As electrostatic repulsion will dominate and
prevent association between the basic regions, we propose that the hydrophobic residues
present in the valine-containing portion of the protein are involved in initiating protein
aggregation. Reduction of the disulfide bond at C240 would result in greater conformational
freedom and exposure of hydrophobic residues in this region, which would increase protein
aggregation. This explains why aggregation proceeds so much more quickly for the reduced
WT and C240A monomer. The addition of TFE likely stabilizes helicity of the Leu-
containing region, providing enhanced rigidity and reduced dynamic motion in the Val-
containing region that would diminish solvent exposure and prevent self-association. Based
upon our experimental evidence along with the results acquired using the computational
tools identified above, we have created a model that depicts the aggregation mechanism of
ATF5 (Figure 10). In using such a simple system to investigate protein aggregation, we have
clear evidence to support the notion that increasing the structural integrity of native α-
helices improves protein physical stability. This conclusion has implications for handling
other helical proteins in vitro and provides a basis for further investigating amorphous
aggregation at higher resolution.
Ciaccio and Laurence Page 9














Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
The authors thank Dr. Russ Middaugh and Brooke Barrett for their technical assistance and discussion of the data
and manuscript. This publication was made possible by NIH Grant Number P20 RR-17708 from the National
Center for Research Resources and the Kansas University Center for Research. Additional support was provided by
the Madison and Lila Self Graduate Fellowship for N. Ciaccio.
References
1. Hermeling S, Schellekens H, Maas C, Gebbink MF, Crommelin DJ, Jiskoot W. Antibody response
to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends
on type and level of aggregation. J Pharm Sci. 2006; 95(5):1084–1096. [PubMed: 16552750]
2. Purohit VS, Middaugh CR, Balasubramanian SV. Influence of aggregation on immunogenicity of
recombinant human Factor VIII in hemophilia A mice. J Pharm Sci. 2006; 95(2):358–371.
[PubMed: 16372314]
3. Schellekens H. How to predict and prevent the immunogenicity of therapeutic proteins. Biotechnol
Annu Rev. 2008; 14:191–202. [PubMed: 18606364]
4. Pecher P, Arnold U. The effect of additional disulfide bonds on the stability and folding of
ribonuclease A. Biophys Chem. 2008
5. Kumar S, Ravi VK, Swaminathan R. How do surfactants and DTT affect the size, dynamics, activity
and growth of soluble lysozyme aggregates? Biochem J. 2008; 415(2):275–288. [PubMed:
18549353]
6. Knowles TP, Zahn R. Enhanced stability of human prion proteins with two disulfide bridges.
Biophys J. 2006; 91(4):1494–1500. [PubMed: 16751235]
7. Lu BY, Chang JY. A 3-disulfide mutant of mouse prion protein expression, oxidative folding,
reductive unfolding, conformational stability, aggregation and isomerization. Arch Biochem
Biophys. 2007; 460(1):75–84. [PubMed: 17320038]
8. Huang K, Maiti NC, Phillips NB, Carey PR, Weiss MA. Structure-specific effects of protein
topology on cross-beta assembly: studies of insulin fibrillation. Biochemistry. 2006; 45(34):10278–
10293. [PubMed: 16922503]
9. Dima RI, Thirumalai D. Probing the instabilities in the dynamics of helical fragments from mouse
PrPC. Proc Natl Acad Sci U S A. 2004; 101(43):15335–15340. [PubMed: 15494440]
10. Liu W, Prausnitz JM, Blanch HW. Amyloid fibril formation by peptide LYS (11–36) in aqueous
trifluoroethanol. Biomacromolecules. 2004; 5(5):1818–1823. [PubMed: 15360293]
11. Kunjithapatham R, Oliva FY, Doshi U, Perez M, Avila J, Munoz V. Role for the alpha-helix in
aberrant protein aggregation. Biochemistry. 2005; 44(1):149–156. [PubMed: 15628855]
12. Morgan GJ, Giannini S, Hounslow AM, Craven CJ, Zerovnik E, Turk V, Waltho JP, Staniforth
RA. Exclusion of the native alpha-helix from the amyloid fibrils of a mixed alpha/beta protein. J
Mol Biol. 2008; 375(2):487–498. [PubMed: 18021806]
13. Watzlawik J, Skora L, Frense D, Griesinger C, Zweckstetter M, Schulz-Schaeffer WJ, Kramer ML.
Prion protein helix1 promotes aggregation but is not converted into beta-sheet. J Biol Chem. 2006;
281(40):30242–30250. [PubMed: 17012240]
14. Ciaccio NA, Moreno ML, Bauer RL, Laurence JS. High-yield expression in E. coli and refolding
of the bZIP domain of activating transcription factor 5. Protein Expr Purif. 2008; 62(2):235–243.
[PubMed: 18718539]
15. Weiss MA. Thermal unfolding studies of a leucine zipper domain and its specific DNA complex:
implications for scissor's grip recognition. Biochemistry. 1990; 29(35):8020–8024. [PubMed:
2261459]
16. Priddy TS, Middaugh CR, Carlson GM. Electrostatic changes in phosphorylase kinase induced by
its obligatory allosteric activator Ca2+ Protein Sci. 2007; 16(3):517–527. [PubMed: 17322534]
Ciaccio and Laurence Page 10













17. Wishart DS, Bigam CG, Yao J, Abildgaard F, Dyson HJ, Oldfield E, Markley JL, Sykes BD. 1H,
13C and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR. 1995; 6(2):135–
140. [PubMed: 8589602]
18. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A. NMRPipe: a multidimensional
spectral processing system based on UNIX pipes. J Biomol NMR. 1995; 6(3):277–293. [PubMed:
8520220]
19. TD Goddard, DGK. In.
20. Johnson WC. Analyzing protein circular dichroism spectra for accurate secondary structures.
Proteins. 1999; 35(3):307–312. [PubMed: 10328265]
21. Manning MC, Woody RW. Theoretical CD studies of polypeptide helices: examination of
important electronic and geometric factors. Biopolymers. 1991; 31(5):569–586. [PubMed:
1868170]
22. Zhou NE, Kay CM, Hodges RS. The role of interhelical ionic interactions in controlling protein
folding and stability. De novo designed synthetic two-stranded alpha-helical coiled-coils. J Mol
Biol. 1994; 237(4):500–512. [PubMed: 8151708]
23. Buck M. Trifluoroethanol and colleagues: cosolvents come of age. Recent studies with peptides
and proteins. Q Rev Biophys. 1998; 31(3):297–355. [PubMed: 10384688]
24. Povey JF, Smales CM, Hassard SJ, Howard MJ. Comparison of the effects of 2,2,2-
trifluoroethanol on peptide and protein structure and function. J Struct Biol. 2007; 157(2):329–
338. [PubMed: 16979904]
25. Atkinson RA, Saudek V, Huggins JP, Pelton JT. 1H NMR and circular dichroism studies of the N-
terminal domain of cyclic GMP dependent protein kinase: a leucine/isoleucine zipper.
Biochemistry. 1991; 30(39):9387–9395. [PubMed: 1892839]
26. Santiago-Rivera ZI, Williams JS, Gorenstein DG, Andrisani OM. Bacterial expression and
characterization of the CREB bZip module: circular dichroism and 2D 1H-NMR studies. Protein
Sci. 1993; 2(9):1461–1471. [PubMed: 8401230]
27. Lumb KJ, Carr CM, Kim PS. Subdomain folding of the coiled coil leucine zipper from the bZIP
transcriptional activator GCN4. Biochemistry. 1994; 33(23):7361–7367. [PubMed: 8003501]
28. Ishigaki T, Ohki I, Utsunomiya-Tate N, Tate SI. Chimeric structural stabilities in the coiled-coil
structure of the NECK domain in human lectin-like oxidized low-density lipoprotein receptor 1
(LOX-1). J Biochem. 2007; 141(6):855–866. [PubMed: 17416594]
29. Nikolaev Y, Pervushin K. NMR spin state exchange spectroscopy reveals equilibrium of two
distinct conformations of leucine zipper GCN4 in solution. J Am Chem Soc. 2007; 129(20):6461–
6469. [PubMed: 17469817]
30. O'Shea EK, Rutkowski R, Kim PS. Evidence that the leucine zipper is a coiled coil. Science. 1989;
243(4890):538–542. [PubMed: 2911757]
31. Vinson CR, Sigler PB, McKnight SL. Scissors-grip model for DNA recognition by a family of
leucine zipper proteins. Science. 1989; 246(4932):911–916. [PubMed: 2683088]
32. Peters CS, Liang X, Li S, Kannan S, Peng Y, Taub R, Diamond RH. ATF-7, a novel bZIP protein,
interacts with the PRL-1 protein-tyrosine phosphatase. J Biol Chem. 2001; 276(17):13718–13726.
[PubMed: 11278933]
33. Krittanai C, Johnson WC Jr. The relative order of helical propensity of amino acids changes with
solvent environment. Proteins. 2000; 39(2):132–141. [PubMed: 10737934]
34. Moitra J, Szilak L, Krylov D, Vinson C. Leucine is the most stabilizing aliphatic amino acid in the
d position of a dimeric leucine zipper coiled coil. Biochemistry. 1997; 36(41):12567–12573.
[PubMed: 9376362]
35. Harbury PB, Zhang T, Kim PS, Alber T. A switch between two-, three-, and four-stranded coiled
coils in GCN4 leucine zipper mutants. Science. 1993; 262(5138):1401–1407. [PubMed: 8248779]
36. Podust LM, Krezel AM, Kim Y. Crystal structure of the CCAAT box/enhancer-binding protein
beta activating transcription factor-4 basic leucine zipper heterodimer in the absence of DNA. J
Biol Chem. 2001; 276(1):505–513. [PubMed: 11018027]
37. Junius FK, O'Donoghue SI, Nilges M, Weiss AS, King GF. High resolution NMR solution
structure of the leucine zipper domain of the c-Jun homodimer. J Biol Chem. 1996; 271(23):
13663–13667. [PubMed: 8662824]
Ciaccio and Laurence Page 11













38. Glover JN, Harrison SC. Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-
Jun bound to DNA. Nature. 1995; 373(6511):257–261. [PubMed: 7816143]
39. Schumacher MA, Goodman RH, Brennan RG. The structure of a CREB bZIP.somatostatin CRE
complex reveals the basis for selective dimerization and divalent cation-enhanced DNA binding. J
Biol Chem. 2000; 275(45):35242–35247. [PubMed: 10952992]
40. Miller M, Shuman JD, Sebastian T, Dauter Z, Johnson PF. Structural basis for DNA recognition by
the basic region leucine zipper transcription factor CCAAT/enhancer-binding protein alpha. J Biol
Chem. 2003; 278(17):15178–15184. [PubMed: 12578822]
41. Ellenberger TE, Brandl CJ, Struhl K, Harrison SC. The GCN4 basic region leucine zipper binds
DNA as a dimer of uninterrupted alpha helices: crystal structure of the protein-DNA complex.
Cell. 1992; 71(7):1223–1237. [PubMed: 1473154]
42. Arrigo AP. Gene expression and the thiol redox state. Free Radic Biol Med. 1999; 27(9–10):936–
944. [PubMed: 10569626]
43. Calabresi L, Vecchio G, Longhi R, Gianazza E, Palm G, Wadensten H, Hammarstrom A, Olsson
A, Karlstrom A, Sejlitz T, et al. Molecular characterization of native and recombinant
apolipoprotein A-IMilano dimmer. The introduction of an interchain disulfide bridge remarkably
alters the physicochemical properties of apolipoprotein A-I. J Biol Chem. 1994; 269(51):32168–
32174. [PubMed: 7798214]
44. Alexander ET, Tanaka M, Kono M, Saito H, Rader DJ, Phillips MC. Structural and functional
consequences of the milano mutation (R173C) in human apolipoprotein A-I. J Lipid Res. 2009
45. Obici L, Franceschini G, Calabresi L, Giorgetti S, Stoppini M, Merlini G, Bellotti V. Structure,
function and amyloidogenic propensity of apolipoprotein A-I. Amyloid. 2006; 13(4):191–205.
[PubMed: 17107880]
46. Linding R, Jensen LJ, Diella F, Bork P, Gibson TJ, Russell RB. Protein disorder prediction:
implications for structural proteomics. Structure. 2003; 11:1453–1459. [PubMed: 14604535]
47. Iakoucheva LM, Dunker AK. Order, disorder, and flexibility: prediction from protein sequence.
Structure. 2003; 11(11):1316–1317. [PubMed: 14604521]
48. Fernandez-Escamilla AM, Rousseau F, Schymkowitz J, Serrano L. Prediction of sequence-
dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol.
2004; 22(10):1302–1306. [PubMed: 15361882]
49. Conchillo-Sole O, de Groot NS, Aviles FX, Vendrell J, Daura X, Ventura S. AGGRESCAN: a
server for the prediction and evaluation of "hot spots" of aggregation in polypeptides. BMC
Bioinformatics. 2007; 8:65. [PubMed: 17324296]
50. Trovato A, Seno F, Tosatto SC. The PASTA server for protein aggregation prediction. Protein Eng
Des Sel. 2007; 20(10):521–523. [PubMed: 17720750]
51. Ofran Y, Rost B. Analysing six types of protein-protein interfaces. J Mol Biol. 2003; 325(2):377–
387. [PubMed: 12488102]
Ciaccio and Laurence Page 12














CD absorption spectra of the disulfide-linked ATF5 dimer (red upright triangles) and the
C240A monomer (blue downturned triangles) in the absence (A) or presence (B) of 10 mM
DTT.
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CD absorption at 222 nm of the disulfide-bound ATF5 dimer (red upright triangles) and
C240A monomer (blue downturned triangles) in the absence (A) or presence (B) of 10 mM
DTT as a function of temperature.
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SLS analysis of the disulfide bound ATF5 dimer (red upright triangles) and C240A
monomer (blue downturned triangles) in the absence (A) or presence (B) of 10 mM DTT as
a function of temperature.
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CD absorption spectra of the disulfide-linked ATF5 dimer (A) and the C240A monomer (B)
in the presence of increasing amounts of TFE: purple squares (no TFE), green circles (10%
[v/v] TFE) and blue diamonds (20%[v/v] TFE).
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CD absorption at 222 nm of the disulfide-linked ATF5 dimer (A) and the C240A monomer
(B) as a function of temperature in the presence of increasing amounts of TFE: purple
squares (no TFE), green circles (10%[v/v] TFE) and blue diamonds (20%[v/v] TFE).
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SLS analysis of the disulfide-linked ATF5 dimer (A) and the C240A monomer (B) in the
presence of increasing amounts of TFE: (purple squares) no TFE, (green circles) 10% TFE
and (blue diamonds) 20% TFE.
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2D 1H-15N HSQC spectrum of 0.2 mM 15N-labeled ATF5 WT dimer (red peaks) and
C240A monomer (blue peaks) in 20 mM MES, pH 6.5.
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Helical wheel diagram of an ATF5 homodimer depicting standard coiled-coil interactions.
Favorable interactions that would stabilize formation of a coiled-coil are delineated in black.
Repulsive interactions that would be destabilizing are shown in red. The diagram reveals the
lack of consensus among homotypic interactions to support coiled-coil stabilization.
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Sequence alignment of the bZIP domain of ATF4 and ATF5. The basic residues comprising
the basic DNA binding domain are highlighted in blue. The leucine and valine residue
located in the d-position of the leucine zipper heptad are highlighted in red. The unusual
cysteine residue poised to form an intermolecular disulfide bond is underlined. The region of
ATF5 most likely to form α-helical structure is boxed.
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Aggregation model of ATF5. Slow aggregation of the cross-linked ATF5 dimer is facilitated
by antiparallel association of the disordered valine-containing region (ϕ). Reduction of the
disulfide bond creates the monomeric species, which displays decreased helicity and
participates in fast aggregation through antiparallel alignment of the same valine-containing
region. The N-terminal basic domain is illustrated by the addition of symbols indicating
positive charge (+). The helical portion of the leucine zipper is depicted in blue. Note: A
limited set of arrangements is shown here, but others are equally possible.
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Table 1
Summary of the results from the CD and SLS experiments for the WT and C240A forms of ATF5 in the










WT, no DTT 23.4 ± 0.3 55.5 35,815 ± 2,658
WT + DTT 17.9 ± 0.2 19.9 173,132 ± 4,151
C240A, no DTT 19.0 ± 1.0 15.9 143,560 ± 13,475
C240A + DTT 16.7 ± 0.1 15.1 175,415 ± 1,149
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Table 2
Summary of the results from the CD and SLS experiments for the WT and C240A forms of ATF5 in the
presence of increasing amounts of the co-solvent TFE. A melting temperature could not be calculated for the











WT, no TFE 25.5 ± 0.6 56.0 259,404 ± 15,061
WT, 10% TFE 30.8 ± 0.6 NA 150,731 ± 6,096
WT, 20% TFE 39.3 ± 1.0 NA 139,743 ± 6,404
C240A, no TFE 19.5 ± 0.3 17.2 779,386 ± 87,881
C240A, 10% TFE 30.5 ± 0.3 NA 277,567 ± 13,598
C240A, 20% TFE 42.0 ± 2.2 NA 248,188 ± 9,972
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